GSK Online Education Modules help DHCPs gain over 3000 hours of free verifiable CPD
In April 2016 GSK, the manufacturer of Corsodyl®, Poligrip®, Sensodyne® and Pronamel®, launched four free certified CPD modules. Each provides 1.5 hours of verifiable CPD and so far over 2000 modules have been completed, meaning GSK has provided over 3000 hours of free, verifiable CPD to DHCPs across the country.
The modules focus on a range of topics including gum disease and the Basic Periodontal Examination (BPE), the effects of tooth loss and dentures for patients, the mode of action of NovaMin® in Sensodyne® Repair & Protect and the Basic Erosive Wear Examination. All modules can be completed remotely at a pace that suits the user. There is a selection of multiple-choice questions at the end of each module and, upon answering the questions correctly, the user is issued a certificate for completing the CPD module.
GSK sees delivering quality education and CPD as a core part of its mission and strives to continuously meet the needs of DHCPs through online learning as well as face to face lectures.
Access to all modules, as well as information on GSK products, is available at www.gsk-dentalprofessionals.co.uk
-ENDS-
Product Information
Corsodyl Mint Mouthwash
Active Ingredient: Chlorhexidine digluconate. Indications: Plaque inhibition; gingivitis; maintenance
of oral hygiene; post periodontal surgery or treatment; aphthous ulceration; oral candida. Legal Category: GSL. Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.
Information about this product, including adverse reactions, precautions, contra-indications and method of use can be found at:
https://www.medicines.org.uk/emc/medicine/21648
Trade marks are owned by or licensed to the GSK group of companies.
CHGBI/CHGOC/0036/16
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.